CHARM Therapeutics Inc.

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

• Gary Glick — Executive Officer / Director / Promoter, LONDON, X0
• Rishi Gupta — Director, LONDON, X0
  3 other raises

  • Wilshire Selective Opportunities Program SPC - WilSOP Segregated Portfolio 5 $30.0M of —
  • Delfi Diagnostics, Inc. $34.3M of $60.0M · 57.2%
  • Golden Teak Capital L.P. $800K of —
• Nihal Sinha — Director, LONDON, X0
  1 other raise

  • Antlia Bioscience, Inc. $6.0M of $20.0M · 30.0%
• Matthew McAviney — Director, LONDON, X0
• Mahesh Kudari — Director, LONDON, X0
• Briggs Morrison — Director, LONDON, X0
  1 other raise

  • Crossbow Therapeutics, Inc. $30.3M of $80.0M · 37.8%
• Kim Blackwell — Director, LONDON, X0
  1 other raise

  • FORE US Bio Inc. $70.4M of $109.6M · 64.2%

Placement agents

• No sales compensation reported — direct raise.